Last reviewed · How we verify
Clusters of Autologous Dermal Fibroblasts
Clusters of Autologous Dermal Fibroblasts is a Biologic drug developed by S.Biomedics Co., Ltd.. It is currently in Phase 1 development. Also known as: 3D-F, FECS-DF.
At a glance
| Generic name | Clusters of Autologous Dermal Fibroblasts |
|---|---|
| Also known as | 3D-F, FECS-DF |
| Sponsor | S.Biomedics Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clusters of Autologous Dermal Fibroblasts CI brief — competitive landscape report
- Clusters of Autologous Dermal Fibroblasts updates RSS · CI watch RSS
- S.Biomedics Co., Ltd. portfolio CI
Frequently asked questions about Clusters of Autologous Dermal Fibroblasts
What is Clusters of Autologous Dermal Fibroblasts?
Clusters of Autologous Dermal Fibroblasts is a Biologic drug developed by S.Biomedics Co., Ltd..
Who makes Clusters of Autologous Dermal Fibroblasts?
Clusters of Autologous Dermal Fibroblasts is developed by S.Biomedics Co., Ltd. (see full S.Biomedics Co., Ltd. pipeline at /company/s-biomedics-co-ltd).
Is Clusters of Autologous Dermal Fibroblasts also known as anything else?
Clusters of Autologous Dermal Fibroblasts is also known as 3D-F, FECS-DF.
What development phase is Clusters of Autologous Dermal Fibroblasts in?
Clusters of Autologous Dermal Fibroblasts is in Phase 1.
Related
- Manufacturer: S.Biomedics Co., Ltd. — full pipeline
- Also known as: 3D-F, FECS-DF